Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Notes
Synthesis of VIP-Lipopeptide Using a New Linker to Modify Liposomes: Towards the Development of a Drug Delivery System for Active Targeting
Toru MasakaTakuya MatsudaYingpeng LiYuki KoideAkira TakamiKenji YanoRyosuke ImaiRisa IchiharaNobuhiro YagiHideharu SuzukiHidemasa HikawaKatsuhide TeradaYuusaku Yokoyama
著者情報
ジャーナル フリー HTML
電子付録

2013 年 61 巻 11 号 p. 1184-1187

詳細
抄録

A new component for the solid phase peptide synthesis of lipopeptide, 2-[(4R,5R)-5-({[(9H-fluoren-9-yl)methoxy]carbonylaminomethyl}-2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]acetic acid (2), was designed and synthesized from (−)-2,3-O-isopropylidene-D-threitol (3) in 4 steps. The key step was the selective alkylation of 3 with benzyl bromoacetate in the presence of Cs2CO3. Vasoactive intestinal peptide (VIP)-lipopeptide (1) incorporating this linker was synthesized by solid phase peptide synthesis.

著者関連情報
© 2013 The Pharmaceutical Society of Japan
前の記事 次の記事
feedback
Top